Skip to main content

Advertisement

SpringerLink
Log in

The endometrial lymphatic vasculature: Function and dysfunction

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

The endometrium has a complex and dynamic blood and lymphatic vasculature which undergoes regular cycles of growth and breakdown. While we now have a detailed picture of the endometrial blood vasculature, our understanding of the lymphatic vasculature in the endometrium is limited. Recent studies have illustrated that the endometrium contains a population of lymphatic vessels with restricted distribution in the functional layer relative to the basal layer. The mechanisms responsible for this restricted distribution and the consequences for endometrial function are not known. This review will summarise our current understanding of endometrial lymphatics, including the mechanisms regulating their growth and function. The potential contribution of lymphatic vessels and lymphangiogenic growth factors to various endometrial disorders will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bartelmez GW. Histological studies on the menstruating mucous membrane of the human uterus. Contrib Embryol. 1933;24(142):143–86.

    Google Scholar 

  2. Markee JE. Menstruation in intraocular endometrial transplants in the rhesus monkey Part I. Observations on normal menstrual cycles. Contrib Embryol. 1940;28(177):223–U212.

    Google Scholar 

  3. Pijnenborg R, Vercruysse L, Hanssens A. The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta. 2006;27(9–10):939–58.

    PubMed  Google Scholar 

  4. Chennazhi KP, Nayak NR. Regulation of angiogenesis in the primate endometrium: Vascular endothelial growth factor. Semin Reprod Med. 2009;27(1):80–9.

    PubMed  Google Scholar 

  5. Demir R, Yaba A, Huppertz B. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochem. 2010;112(3):203–14.

    PubMed  Google Scholar 

  6. Fraser HM, Duncan WC. SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium. Reprod Fertil Dev. 2009;21(3):377–92.

    PubMed  Google Scholar 

  7. Girling JE, Rogers PA. Regulation of endometrial vascular remodelling: Role of the vascular endothelial growth factor family and the angiopoietin-TIE signalling system. Reproduction. 2009;138(6):883–93.

    PubMed  Google Scholar 

  8. Plaisier M. Decidualisation and angiogenesis. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):259–71.

    PubMed  Google Scholar 

  9. Hoggan G, Hoggan FE. On the comparative anatomy of the lymphatics of the uterus. J Anat Physiol. 1881;16(Pt 1):50–89.

    PubMed  Google Scholar 

  10. Albrecht I, Christofori G. Molecular mechanisms of lymphangiogenesis in development and cancer. Int J Dev Biol. 2011;55(4–5):483–94.

    PubMed  Google Scholar 

  11. Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17(11):1371–80.

    PubMed  Google Scholar 

  12. Francois M, Harvey NL, Hogan BM. The transcriptional control of lymphatic vascular development. Physiology. 2011;26(3):146–55.

    PubMed  Google Scholar 

  13. Paupert J, Sounni NE, Noel A. Lymphangiogenesis in post-natal tissue remodeling: Lymphatic endothelial cell connection with its environment. Mol Aspects Med. 2011;32(2):146–58.

    PubMed  Google Scholar 

  14. Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011;193(4):607–18.

    PubMed  Google Scholar 

  15. Shields JD. Lymphatics: At the interface of immunity, tolerance, and tumor metastasis. Microcirculation. 2011;18(7):517–31.

    PubMed  Google Scholar 

  16. Uchino S, Ichikawa S, Okubo M, Nakamura Y, Iimura A. Methods of detection of lymphatics and their changes with oestrous cycle. Int Angiol. 1987;6(3):271–8.

    PubMed  Google Scholar 

  17. Ueki M. Histologic study of endometriosis and examination of lymphatic drainage in and from the uterus. Am J Obstet Gynecol. 1991;165(1):201–9.

    PubMed  Google Scholar 

  18. Blackwell PM, Fraser IS. Superficial lymphatics in the functional zone of normal human endometrium. Microvasc Res. 1981;21(2):142–52.

    PubMed  Google Scholar 

  19. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A. 1995;92(8):3566–70.

    PubMed  Google Scholar 

  20. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144(4):789–801.

    PubMed  Google Scholar 

  21. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154(2):385–94.

    PubMed  Google Scholar 

  22. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98(6):769–78.

    PubMed  Google Scholar 

  23. Donoghue JF, Lederman FL, Susil BJ, Rogers PA. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod. 2007;22(6):1705–13.

    PubMed  Google Scholar 

  24. Hey-Cunningham AJ, Ng FW, Busard MPH, Berbic M, Manconi F, Young L, et al. Uterine lymphatic and blood micro-vessels in women with endometriosis through the menstrual cycle. J Endometriosis. 2010;2(4):197–204.

    Google Scholar 

  25. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Gatter KC, Harris AL, et al. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol. 2005;58(2):202–6.

    PubMed  Google Scholar 

  26. Red-Horse K. Lymphatic vessel dynamics in the uterine wall. Placenta. 2008;29(Suppl A):S55–9.

    PubMed  Google Scholar 

  27. Red-Horse K, Rivera J, Schanz A, Zhou Y, Winn V, Kapidzic M, et al. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest. 2006;116(10):2643–52.

    PubMed  Google Scholar 

  28. Donoghue JF, McGavigan CJ, Lederman FL, Cann LM, Fu L, Dimitriadis E, et al. Dilated thin-walled blood and lymphatic vessels in human endometrium: A potential role for VEGF-D in progestin-induced break-through bleeding. PLoS One. 2012;7(2):e30916.

    PubMed  Google Scholar 

  29. Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS. 2004;112(7–8):526–38.

    PubMed  Google Scholar 

  30. Jackson DG. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev. 2009;230(1):216–31.

    PubMed  Google Scholar 

  31. Lea RG, Sandra O. Immunoendocrine aspects of endometrial function and implantation. Reproduction. 2007;134(3):389–404.

    PubMed  Google Scholar 

  32. Volchek M, Girling JE, Lash GE, Cann L, Kumar B, Robson SC, et al. Lymphatics in the human endometrium disappear during decidualization. Hum Reprod. 2010;25(10):2455–64.

    PubMed  Google Scholar 

  33. Gellersen B, Brosens IA, Brosens JJ. Decidualization of the human endometrium: Mechanisms, functions, and clinical perspectives. Semin Reprod Med. 2007;25(6):445–53.

    PubMed  Google Scholar 

  34. Makrigiannakis A, Petsas G, Toth B, Relakis K, Jeschke U. Recent advances in understanding immunology of reproductive failure. J Reprod Immunol. 2011;90(1):96–104.

    PubMed  Google Scholar 

  35. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: The role of the immune system at the implantation site. Ann N Y Acad Sci. 2011;1221:80–7.

    PubMed  Google Scholar 

  36. Warning JC, McCracken SA, Morris JM. A balancing act: Mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction. 2011;141(6):715–24.

    PubMed  Google Scholar 

  37. Collins MK, Tay CS, Erlebacher A. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest. 2009;119(7):2062–73.

    PubMed  Google Scholar 

  38. Critchley HO, Maybin JA. Molecular and cellular causes of abnormal uterine bleeding of endometrial origin. Semin Reprod Med. 2011;29(5):400–9.

    PubMed  Google Scholar 

  39. Henriet P, Gaide Chevronnay HP, Marbaix E. The endocrine and paracrine control of menstruation. Mol Cell Endocrinol. 2012;358(2):197–207.

    PubMed  Google Scholar 

  40. Salamonsen LA. Local regulators and the establishment of pregnancy: A review. Reprod Fertil Dev. 1992;4(2):125–34.

    PubMed  Google Scholar 

  41. Salamonsen LA. Tissue injury and repair in the female human reproductive tract. Reproduction. 2003;125(3):301–11.

    PubMed  Google Scholar 

  42. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8(6):464–78.

    PubMed  Google Scholar 

  43. Adams RH, Eichmann A. Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol. 2010;2(5):a001875.

    PubMed  Google Scholar 

  44. Arese M, Serini G, Bussolino F. Nervous vascular parallels: Axon guidance and beyond. Int J Dev Biol. 2011;55(4–5):439–45.

    PubMed  Google Scholar 

  45. Melani M, Weinstein BM. Common factors regulating patterning of the nervous and vascular systems. Annu Rev Cell Dev Biol. 2010;26:639–65.

    PubMed  Google Scholar 

  46. Baldwin ME, Stacker SA, Achen MG. Molecular control of lymphangiogenesis. Bioessays. 2002;24(11):1030–40.

    PubMed  Google Scholar 

  47. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol. 2008;3:367–97.

    PubMed  Google Scholar 

  48. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010;140(4):460–76.

    PubMed  Google Scholar 

  49. Lash GE, Innes BA, Drury JA, Robson SC, Quenby S, Bulmer JN. Localization of angiogenic growth factors and their receptors in the human endometrium throughout the menstrual cycle and in recurrent miscarriage. Hum Reprod. 2012;27(1):183–95.

    PubMed  Google Scholar 

  50. Mints M, Blomgren B, Falconer C, Palmblad J. Expression of the vascular endothelial growth factor (VEGF) family in human endometrial blood vessels. Scand J Clin Lab Invest. 2002;62(3):167–75.

    PubMed  Google Scholar 

  51. Moller B, Lindblom B, Olovsson M. Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle. Acta Obstet Gynecol Scand. 2002;81(9):817–24.

    PubMed  Google Scholar 

  52. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, et al. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res. 2003;9(4):1361–9.

    PubMed  Google Scholar 

  53. Graubert MD, Ortega MA, Kessel B, Mortola JF, Iruela-Arispe ML. Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1. Am J Pathol. 2001;158(4):1399–410.

    PubMed  Google Scholar 

  54. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 2004;25(4):581–611.

    PubMed  Google Scholar 

  55. Harper SJ, Bates DO. VEGF-A splicing: The key to anti-angiogenic therapeutics? Nat Rev Cancer. 2008;8(11):880–7.

    PubMed  Google Scholar 

  56. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci. 2001;114(Pt 5):853–65.

    PubMed  Google Scholar 

  57. Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers. 2006;10(4):515–27.

    PubMed  Google Scholar 

  58. Walter LM, Rogers PA, Girling JE. Differential expression of vascular endothelial growth factor-A isoforms in the mouse uterus during early pregnancy. Reprod Biomed Online. 2010;21(6):803–11.

    PubMed  Google Scholar 

  59. Walter LM, Rogers PA, Girling JE. Vascular endothelial growth factor-A isoform and (co)receptor expression are differentially regulated by 17beta-oestradiol in the ovariectomised mouse uterus. Reproduction. 2010;140(2):331–41.

    PubMed  Google Scholar 

  60. Hornung D, Lebovic DI, Shifren JL, Vigne JL, Taylor RN. Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil Steril. 1998;69(5):909–15.

    PubMed  Google Scholar 

  61. Hannan NJ, Paiva P, Meehan KL, Rombauts LJ, Gardner DK, Salamonsen LA. Analysis of fertility-related soluble mediators in human uterine fluid identifies VEGF as a key regulator of embryo implantation. Endocrinology. 2011;152(12):4948–56.

    PubMed  Google Scholar 

  62. Dunk C, Ahmed A. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol Histopathol. 2001;16(2):359–75.

    PubMed  Google Scholar 

  63. Eastabrook GD, Hu Y, Tan R, Dutz JP, Maccalman CD, von Dadelszen P. Decidual NK cell-derived conditioned medium (dNK-CM) mediates VEGF-C secretion in extravillous cytotrophoblasts. Am J Reprod Immunol. 2012;67(2):101–11.

    PubMed  Google Scholar 

  64. Fitzpatrick TE, Lash GE, Yanaihara A, Charnock-Jones DS, Macdonald-Goodfellow SK, Graham CH. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor. Exp Cell Res. 2003;283(2):247–55.

    PubMed  Google Scholar 

  65. Schiessl B, Innes BA, Bulmer JN, Otun HA, Chadwick TJ, Robson SC, et al. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta. 2009;30(1):79–87.

    PubMed  Google Scholar 

  66. Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol. 2009;182(7):4085–92.

    PubMed  Google Scholar 

  67. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006;80(3):572–80.

    PubMed  Google Scholar 

  68. Girling JE, Donoghue JF, Lederman FL, Cann LM, Achen MG, Stacker SA, et al. Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer. Reprod Biol Endocrinol. 2010;8:84.

    PubMed  Google Scholar 

  69. McColl BK, Stacker SA, Achen MG. Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis. APMIS. 2004;112(7–8):463–80.

    PubMed  Google Scholar 

  70. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359–71.

    PubMed  Google Scholar 

  71. Germeyer A, Hamilton AE, Laughlin LS, Lasley BL, Brenner RM, Giudice LC, et al. Cellular expression and hormonal regulation of neuropilin-1 and −2 messenger ribonucleic Acid in the human and rhesus macaque endometrium. J Clin Endocrinol Metab. 2005;90(3):1783–90.

    PubMed  Google Scholar 

  72. Hess AP, Schanz A, Baston-Buest DM, Hirchenhain J, Stoff-Khalili MA, Bielfeld P, et al. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium. J Reprod Immunol. 2009;79(2):129–36.

    PubMed  Google Scholar 

  73. Jee BC, Suh CS, Kim KC, Lee WD, Kim H, Kim SH. Expression of vascular endothelial growth factor-A and its receptor-1 in a luteal endometrium in patients with repeated in vitro fertilization failure. Fertil Steril. 2009;91(2):528–34.

    PubMed  Google Scholar 

  74. Kim CH, Ahn JW, Kim SH, Chae HD, Kang BM. Effects on in vitro fertilization-embryo transfer outcomes of vascular endothelial growth factor receptor-1, −2 and −3 in eutopic endometrial tissue of women with endometriosis. J Obstet Gynaecol Res. 2011;37(11):1631–7.

    PubMed  Google Scholar 

  75. Meduri G, Bausero P, Perrot-Applanat M. Expression of vascular endothelial growth factor receptors in the human endometrium: Modulation during the menstrual cycle. Biol Reprod. 2000;62(2):439–47.

    PubMed  Google Scholar 

  76. Mints M, Blomgren B, Palmblad J. Expression of vascular endothelial growth factor receptor-3 in the endometrium in menorrhagia. Int J Mol Med. 2007;19(6):909–13.

    PubMed  Google Scholar 

  77. Mints M, Hultenby K, Zetterberg E, Blomgren B, Falconer C, Rogers R, et al. Wall discontinuities and increased expression of vascular endothelial growth factor-A and vascular endothelial growth factor receptors 1 and 2 in endometrial blood vessels of women with menorrhagia. Fertil Steril. 2007;88(3):691–7.

    PubMed  Google Scholar 

  78. Pavelock K, Braas K, Ouafik L, Osol G, May V. Differential expression and regulation of the vascular endothelial growth factor receptors neuropilin-1 and neuropilin-2 in rat uterus. Endocrinology. 2001;142(2):613–22.

    PubMed  Google Scholar 

  79. Punyadeera C, Thijssen VL, Tchaikovski S, Kamps R, Delvoux B, Dunselman GA, et al. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod. 2006;12(6):367–75.

    PubMed  Google Scholar 

  80. Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction. 2002;123(3):379–87.

    PubMed  Google Scholar 

  81. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009;21(2):154–65.

    PubMed  Google Scholar 

  82. Shibuya M. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep. 2008;41(4):278–86.

    PubMed  Google Scholar 

  83. Hay DL, Walker CS, Poyner DR. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: Opportunities and challenges. Endocr Relat Cancer. 2011;18(1):C1–14.

    PubMed  Google Scholar 

  84. Maybin JA, Battersby S, Hirani N, Nikitenko LL, Critchley HO, Jabbour HN. The expression and regulation of adrenomedullin in the human endometrium: A candidate for endometrial repair. Endocrinology. 2011;152(7):2845–56.

    PubMed  Google Scholar 

  85. Hirchenhain J, Huse I, Hess A, Bielfeld P, De Bruyne F, Krussel JS. Differential expression of angiopoietins 1 and 2 and their receptor Tie-2 in human endometrium. Mol Hum Reprod. 2003;9(11):663–9.

    PubMed  Google Scholar 

  86. Lee YL, Liu Y, Ng PY, Lee KF, Au CL, Ng EH, et al. Aberrant expression of angiopoietins-1 and −2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation. Hum Reprod. 2008;23(4):894–903.

    PubMed  Google Scholar 

  87. Nayak NR, Kuo CJ, Desai TA, Wiegand SJ, Lasley BL, Giudice LC, et al. Expression, localization and hormonal control of angiopoietin-1 in the rhesus macaque endometrium: Potential role in spiral artery growth. Mol Hum Reprod. 2005;11(11):791–9.

    PubMed  Google Scholar 

  88. Rogers PA, Abberton KM. Endometrial arteriogenesis: Vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders. Microsc Res Tech. 2003;60(4):412–9.

    PubMed  Google Scholar 

  89. Stefansson IM, Salvesen HB, Akslen LA. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res. 2006;66(6):3303–9.

    PubMed  Google Scholar 

  90. Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, et al. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci. 2008;99(5):914–9.

    PubMed  Google Scholar 

  91. Briet JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, et al. Lymphvascular space involvement: An independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96(3):799–804.

    PubMed  Google Scholar 

  92. Mannelqvist M, Stefansson I, Salvesen HB, Akslen LA. Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. Histopathology. 2009;54(2):174–83.

    PubMed  Google Scholar 

  93. Miyakuni Y, Matsumoto T, Arakawa A, Sonoue H, Suzuki C, Takeda S. Lymphatic invasion according to D2-40 immunostaining is a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus. Pathol Int. 2008;58(8):471–6.

    PubMed  Google Scholar 

  94. O’Brien DJ, Flannelly G, Mooney EE, Foley M. Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality. BJOG. 2009;116(7):991–4.

    PubMed  Google Scholar 

  95. Van Trappen PO, Pepper MS. Lymphangiogenesis in human gynaecological cancers. Angiogenesis. 2005;8(2):137–45.

    PubMed  Google Scholar 

  96. Pengchong H, Tao H. Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma. Eur J Gynaecol Oncol. 2011;32(6):660–4.

    PubMed  Google Scholar 

  97. Takahashi K, Saga Y, Mizukami H, Takei Y, Urabe M, Kume A, et al. Development of a mouse model for lymph node metastasis with endometrial cancer. Cancer Sci. 2011;102(12):2272–7.

    PubMed  Google Scholar 

  98. Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad. 2008;1127:106–15.

    Google Scholar 

  99. Sampson JA. Heterotopic or misplaced endometrial tissue. Am J Obstet Gynecol. 1925;10:649–64.

    Google Scholar 

  100. Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue, into the venous circulation. Am J Pathol. 1927;3(2):93–U42.

    PubMed  Google Scholar 

  101. Mechsner S, Weichbrodt M, Riedlinger WF, Bartley J, Kaufmann AM, Schneider A, et al. Estrogen and progestogen receptor positive endometriotic lesions and disseminated cells in pelvic sentinel lymph nodes of patients with deep infiltrating rectovaginal endometriosis: A pilot study. Hum Reprod. 2008;23(10):2202–9.

    PubMed  Google Scholar 

  102. Mechsner S, Weichbrodt M, Riedlinger WF, Kaufmann AM, Schneider A, Kohler C. Immunohistochemical evaluation of endometriotic lesions and disseminated endometriosis-like cells in incidental lymph nodes of patients with endometriosis. Fertil Steril. 2010;94(2):457–63.

    PubMed  Google Scholar 

  103. Tempfer CB, Wenzl R, Horvat R, Grimm C, Polterauer S, Buerkle B, et al. Lymphatic spread of endometriosis to pelvic sentinel lymph nodes: A prospective clinical study. Fertil Steril. 2011;96(3):692–6.

    PubMed  Google Scholar 

  104. Keichel S, Barcena de Arellano ML, Reichelt U, Riedlinger WF, Schneider A, Kohler C, et al. Lymphangiogenesis in deep infiltrating endometriosis. Hum Reprod. 2011;26(10):2713–20.

    PubMed  Google Scholar 

  105. Reichelt U, Keichel S, Barcena de Arellano ML, Chiantera V, Schneider A, Mechsner S (2012) High lymph vessel density and expression of lymphatic growth factors in peritoneal endometriosis. Reprod Sci, Epub ahead of print.

  106. Gong Y, Tempfer CB. Regional lymphatic spread in women with pelvic endometriosis. Med Hypotheses. 2011;76(4):560–3.

    PubMed  Google Scholar 

  107. Rodgers AK, Falcone T. Treatment strategies for endometriosis. Expert Opin Pharmacother. 2008;9(2):243–55.

    PubMed  Google Scholar 

  108. Rodriguez MI, Warden M, Darney PD. Intrauterine progestins, progesterone antagonists, and receptor modulators: A review of gynecologic applications. Am J Obstet Gynecol. 2010;202(5):420–8.

    PubMed  Google Scholar 

  109. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: A systematic review. BJOG. 2001;108(1):74–86.

    PubMed  Google Scholar 

  110. d’Arcangues C. Management of vaginal bleeding irregularities induced by progestin-only contraceptives. Hum Reprod. 2000;15 Suppl 3:24–9.

    PubMed  Google Scholar 

  111. Findlay JK. Future directions for research on endometrial bleeding. Hum Reprod. 1996;11 Suppl 2:179–83.

    PubMed  Google Scholar 

  112. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod. 1998;13(5):1210–7.

    PubMed  Google Scholar 

  113. Fraser IS, Hickey M. Endometrial vascular changes and bleeding disturbances with long-acting progestins. Steroids. 2000;65(10–11):665–70.

    PubMed  Google Scholar 

  114. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol. 1998;105(6):592–8.

    PubMed  Google Scholar 

  115. McGavigan CJ, Dockery P, Metaxa-Mariatou V, Campbell D, Stewart CJ, Cameron IT, et al. Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel. Hum Reprod. 2003;18(1):77–84.

    PubMed  Google Scholar 

  116. Rogers PA. Endometrial vasculature in Norplant users. Hum Reprod. 1996;11 Suppl 2:45–50.

    PubMed  Google Scholar 

  117. Rogers PA, Au CL, Affandi B. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod. 1993;8(9):1396–404.

    PubMed  Google Scholar 

  118. Song JY, Fraser IS. Effects of progestogens on human endometrium. Obstet Gynecol Surv. 1995;50(5):385–94.

    PubMed  Google Scholar 

  119. Hickey M, Dwarte D, Fraser IS. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum Reprod. 2000;15(7):1509–14.

    PubMed  Google Scholar 

  120. Mints M, Blomgren B, Falconer C, Fianu-Jonasson A, Palmblad J. Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia. Fertil Steril. 2005;84(3):692–700.

    PubMed  Google Scholar 

  121. Andraweera PH, Dekker GA, Roberts CT. The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Updat. 2012;18(4):436–57.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gynaecology Research Centre, Department of Obstetrics and Gynaecology, The University of Melbourne, The Royal Women’s Hospital, Cnr Flemington Rd and Grattan St, Parkville, VIC, 3058, Australia

    Jane E. Girling & Peter A. W. Rogers

Authors
  1. Jane E. Girling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter A. W. Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jane E. Girling.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Girling, J.E., Rogers, P.A.W. The endometrial lymphatic vasculature: Function and dysfunction. Rev Endocr Metab Disord 13, 265–275 (2012). https://doi.org/10.1007/s11154-012-9224-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-012-9224-6

Keywords

Search

Navigation